We are live on ! Find out more
ZIVO

Zivo Bioscience, Inc. Common Stock
ZIVO

Delisted

ZIVO was delisted on the 24th of November, 2023.

Back to rankings

7 hedge funds and large institutions have $195K invested in Zivo Bioscience, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$143K
2
Wells Fargo
Wells Fargo
California
+$30.3K
3
BC
Bartlett & Co
Ohio
+$4.54K
4
BCWM
Bartlett & Co Wealth Management
Ohio
+$4.54K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$2.83K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
1
Commonwealth Equity Services
Massachusetts
$149K +$143K +5,273 New
Wells Fargo
2
Wells Fargo
California
$32K +$30.3K +1,115 New
BC
3
Bartlett & Co
Ohio
$5K +$4.54K +167 New
BCWM
4
Bartlett & Co Wealth Management
Ohio
$4.74K +$4.54K +167 New
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$3K +$2.83K +104 New
Morgan Stanley
6
Morgan Stanley
New York
$1K +$571 +21 New
Osaic Holdings
7
Osaic Holdings
Arizona
– +$27 +1 New

ZIVO Hedge Fund Activity: Q2 2021 in Review

7 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q2 2021, worth a combined $195K.

Buyers outnumbered sellers: 7 funds opened new ZIVO positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $143K.

  • 7 institutional investors held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $195K of Zivo Bioscience, Inc. Common Stock stock for Q2 2021.
  • 7 funds opened new Zivo Bioscience, Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +7 holders.
  • The largest Zivo Bioscience, Inc. Common Stock buyer in Q2 2021 was Commonwealth Equity Services, an estimated $143K added.

Based on aggregated 13F filings for Q2 2021.